Pharmacoeconomic viewpoints on volatile anaesthesia - "Much ado about nothing?" [5]

Anaesthesia and Intensive Care

Volumn 33, Issue 1, 2005, Pages 144-145

  Rapeport, D ^a   Harper, S ^a   Flisberg, P ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; SEVOFLURANE;

ANESTHESIA INDUCTION; CALCULATION; CONTROLLED STUDY; DRUG COST; DRUG DELIVERY SYSTEM; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LETTER; LIQUID; MATHEMATICAL COMPUTING; PHYSICAL PARAMETERS; VAPOR;

ANESTHETICS, INHALATION; ECONOMICS, PHARMACEUTICAL; METHYL ETHERS;

EID: 14244268274     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Suttner S, Boldt, J, Schmidt C, Piper S, Kumle B. Cost analysis of target-controlled infusion - based anesthesia compared with standard anesthesia regimens. Anesth Analg 1999; 88:77-82.
2. Rosenberg MK, Bridge P, Brown M. Cost comparison: A desflurane- versus a propofol-based general anesthetic technique. Anesth Analg 1994; 79:852-855.
3. Dion P. The cost of anaesthetic vapours. Can J Anaesth 1992; 39:633.
4. Rowe WL. Economics and anaesthesia. Anaesthesia 1998; 53:782-788.
5. Beers RA, Calimlim R, Uddoh E, Esposito BF, Camporesi EM. A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecological surgery. Anesth Analg 2000; 91:1420-1425.
6. Loop T, Priebe H.-J. Prospective, randomized cost analysis of anesthesia with remifentanil combined with propofol, desflurane or sevoflurane for otorhinolaryngeal surgery. Acta Anaesthesiol Scand 2002; 46:1251-1260.